Aggressive subtypes in basal cell carcinomas might need different treatment and follow-up due to the higher risk of surgically uncontrollable recurrences

由于侵袭性基底细胞癌亚型复发风险较高且手术难以控制,因此可能需要不同的治疗和随访方案。

阅读:1

Abstract

PURPOSE: Basal cell carcinoma (BCC) is the most frequent malignant tumor of the eyelid and recurrences of BCC may lead to massive destruction of the orbital region. The objective of this study was to evaluate predictors for surgically difficult-to-control or uncontrollable recurrences. METHODS: All BCCs of the periorbital region treated in the Department of Dermatology or Ophthalmology between 2011 and 2021 were included in a retrospective single center study and divided into a group of primary BCCs (pBCCs) and a group of recurrent BCCs (rBCCs). The following risk factors were compared between the two groups using the Chi(2) test: tumor localization, histological subtype and presence of R1 situation. Furthermore, difference in severity of reconstruction between pBCCs and rBCCs was analyzed. P-value < 0.05 was considered statistically significant. RESULTS: Data from 474 pBCCs and 33 rBCCs were included in this retrospective analysis. Both R1 status (p < 0.001) and aggressive subtype (p = 0.028) were significant risk factors for recurrence. The two most frequent reasons for R1 were the patient's rejection of further surgical intervention (n = 4) and the fact that the surgery was not performed at a specialized center (n = 6). In 10 of the 33 rBCCs, a further recurrence occurred despite R0 status and all 10 cases showed an aggressive subtype (p = 0.020). In all BCCs with R1 status, there was no significant difference in the recurrence rate regarding the subtype. CONCLUSION: Our results show the impact of incomplete tumor resection and aggressive subtype on patient outcome after BCC surgery. We suggest that the aggressiveness of the BCC may be the precondition for multiple recurring BCCs. Furthermore, especially patients who underwent surgery outside our Departments showed R1 situations and rBCCs. Therefore, personalized treatment and follow-up care as well as efforts to avoid high-risk recurrences with aggressive subtypes are necessary to improve long-term success after surgery and should be conducted by a specialized center.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。